05/27/2020
2:14 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2020
4:21 PM | Arcturus Therapeutics Holdings Inc. (Subject)
Ultragenyx Pharmaceutical (Filed by)
| Form SC 13D/A
| |
05/22/2020
12:41 PM | Arcturus Therapeutics Holdings Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
6:50 PM | Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
6:49 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
6:15 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
6:13 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
6:12 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
7:25 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2020
3:31 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/11/2020
12:21 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
05/08/2020
7:12 PM | Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:11 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:10 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:08 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:06 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:04 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
7:02 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
6:56 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2020
6:55 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2020
12:00 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:39 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:37 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:36 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:35 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:34 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:33 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:32 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
2:31 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2020
5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2020
11:59 AM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2020
3:05 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2020
6:44 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4/A
| |
03/03/2020
7:02 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
7:00 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:58 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:56 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:55 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:53 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:47 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:46 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2020
6:45 PM | Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
5:04 AM | Ultragenyx Pharmaceutical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2020
8:10 AM | BlackRock Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A
| |
01/31/2020
12:58 PM | Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2020
12:08 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2020
3:25 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2020
2:11 PM | Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
12/18/2019
7:30 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2019
3:07 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2019
6:32 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:31 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:30 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:29 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:28 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:27 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:25 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:24 PM | Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
6:21 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2019
9:45 AM | Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
10/07/2019
6:40 PM | Hogenhuis Wladimir (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2019
6:25 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
11:35 AM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
5:04 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2019
7:41 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2019
7:35 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2019
4:02 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2019
6:40 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
5:15 PM | Arcturus Therapeutics Holdings Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2019
8:16 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
7:05 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
7:01 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2019
3:33 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
3:05 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2019
4:00 PM | Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:53 PM | SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:50 PM | Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:48 PM | SIEGALL CLAY B (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:46 PM | NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:44 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:40 PM | Ekman Lars (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:38 PM | Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
5:59 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
5:56 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
5:54 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
5:51 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
5:49 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2019
5:36 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
4:46 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
4:44 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
4:41 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
4:39 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
6:07 PM | Sharp Shalini (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
6:04 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
6:01 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
5:57 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
5:55 PM | Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
5:52 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
5:50 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
